What does anti-Müllerian hormone tell you about ovarian function?

Clinical Endocrinology

Volumn 77, Issue 5, 2012, Pages 652-655

  Anderson, Richard A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ARTICLE; BIRTH; DIAGNOSTIC TEST; FEMALE; HIGH RISK POPULATION; HORMONE SYNTHESIS; HUMAN; INFERTILITY THERAPY; LIFESPAN; MEASUREMENT; MENOPAUSE; OVARIAN RESERVE; OVARY DEVELOPMENT; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PUBERTY; REPRODUCTION;

ANTI-MULLERIAN HORMONE; FEMALE; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 84867250730     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04451.x     Document Type: Article

References (29)

1. Broekmans, F.J., Soules, M.R., &, Fauser, B.C., (2009) Ovarian aging: mechanisms and clinical consequences. Endocrine Reviews, 30, 465-493.
2. Hutson, J., Ikawa, H., &, Donahoe, P.K., (1981) The ontogeny of Mullerian inhibiting substance in the gonads of the chicken. Journal of Pediatric Surgery, 16, 822-827. (Pubitemid 12212852)
3. Weenen, C., Laven, J.S., Von Bergh, A.R., et al,. (2004) Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction, 10, 77-83. (Pubitemid 38196508)
4. Andersen, C.Y., Schmidt, K.T., Kristensen, S.G., et al,. (2010) Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles. Human Reproduction, 25, 1282-1287.
5. van Rooij, I.A.J., Broekmans, F.J.M., te Velde, E.R., et al,. (2002) Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Human Reproduction, 17, 3065-3071. (Pubitemid 35469254)
6. Nelson, S.M., Yates, R.W., &, Fleming, R., (2007) Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy. Human Reproduction, 22, 2414-2421. (Pubitemid 47289055)
7. Hansen, K.R., Hodnett, G.M., Knowlton, N., et al,. (2011) Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertility and Sterility, 95, 170-175.
8. van Rooij, I.A.J., Broekmans, F.J.M., Scheffer, G.J., et al,. (2005) Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertility and Sterility, 83, 979-987.
9. Nelson, S.M., Messow, M.C., Wallace, A.M., et al,. (2011) Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients. Fertility and Sterility, 95, 736-741.
10. Sowers, M.R., Eyvazzadeh, A.D., McConnell, D., et al,. (2008) Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. Journal of Clinical Endocrinology and Metabolism, 93, 3478-3483.
11. Broer, S.L., Eijkemans, M.J., Scheffer, G.J., et al,. (2011) Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. Journal of Clinical Endocrinology and Metabolism, 96, 2532-2539.
12. Tehrani, F.R., Solaymani-Dodaran, M., &, Azizi, F., (2009) A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause, 16, 797-802.
13. Freeman, E.W., Sammel, M.D., Lin, H., et al,. (2012) Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. Journal of Clinical Endocrinology and Metabolism, 97, 1673-1680.
14. Anderson, R.A., &, Cameron, D.A., (2011) Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. Journal of Clinical Endocrinology and Metabolism, 96, 1336-1343.
15. Anderson, R.A., Themmen, A.P.N., Al Qahtani, A., et al,. (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reproduction, 21, 2583-2592. (Pubitemid 44542149)
16. van den Berg, M.H., van Dulmen-den Broeder, E., Overbeek, A., et al,. (2010) Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Human Reproduction, 25, 1520-1527.
17. Nelson, S.M., Stewart, F., Fleming, R., et al,. (2010) Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertility and Sterility, 93, 1356-1358.
18. Jonard, S., Pigny, P., Jacquesson, L., et al,. (2005) The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea. Human Reproduction, 20, 101-107.
19. Li, H.W., Anderson, R.A., Yeung, W.S., et al,. (2011) Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea. Fertility and Sterility, 96, 774-779.
20. Tran, N.D., Cedars, M.I., &, Rosen, M.P., (2011) The role of anti-Müllerian hormone (AMH) in assessing ovarian reserve. Journal of Clinical Endocrinology and Metabolism, 96, 3609-3614.
21. Kelsey, T.W., Wright, P., Nelson, S.M., et al,. (2011) A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS ONE, 6, e22024.
22. Hagen, C.P., Aksglaede, L., Sorensen, K., et al,. (2012) Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Human Reproduction, 27, 861-866.
23. Kelsey, T.W., Anderson, R.A., Wright, P., et al,. (2012) Data-driven assessment of the human ovarian reserve. Molecular Human Reproduction, 18, 79-87.
24. Brougham, M.F.H., Crofton, P., Johnson, E.J., et al,. (2012) Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and post-pubertal girls treated for cancer: a prospective study. Journal of Clinical Endocrinology and Metabolism, 97, 2059-2067.
25. Pigny, P., Merlen, E., Robert, Y., et al,. (2003) Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. Journal of Clinical Endocrinology and Metabolism, 88, 5957-5962. (Pubitemid 38033078)
26. Dewailly, D., Gronier, H., Poncelet, E., et al,. (2011) Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Human Reproduction, 26, 3123-3129.
27. La Marca, A., &, Volpe, A., (2007) The Anti-Mullerian hormone and ovarian cancer. Human Reproduction Update, 13, 265-273. (Pubitemid 47061633)
28. Ahmed, S.F., &, Rodie, M., (2010) Investigation and initial management of ambiguous genitalia. Best Practice & Research. Clinical Endocrinology & Metabolism, 24, 197-218.
29. Wallace, W.H., &, Kelsey, T.W., (2010) Human ovarian reserve from conception to the menopause. PLoS ONE, 5, e8772.